An Emotion-Focused Intervention for Glycemic Control in T2D

Type2 Diabetes Clinical Trial

Official title:

An Emotion-Focused Psychosocial Intervention for Improved Glycemic Control in T2D Patients: A Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03553680
• Other study ID #: 17-0635
• Status: Completed
• Phase: N/A
• Start date: October 20, 2017
• Est. completion date: October 19, 2018

Study information

• Verified date: May 2018
• Source: University of Chicago
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary aim of this proposed project is to collect pilot data using an Emotion-Focused CBT Psycho-social Intervention i individuals with T2D to obtain the effect sizes on hypothesized changes in Negative Emotionality, Diabetes Distress, and HbA1c values that will be needed for a more appropriately sized clinical trial for an RO1 submission to the National Institutes of Health.

Description:

Our interest in aberrant Emotional Regulation / Emotional Intelligence in Type 2 Diabetes stems from observations that while many patients with Type 2 Diabetes have greater incidence of mood and anxiety (and even anger) disorders than controls, targeting psychiatric conditions, such as depression, is not sufficient to improve glycemic control in patients with diabetes. Thus, the key issue for such patients is not what specific psychiatric disorder they have, but the presence of an impairment in the fundamental regulation of emotional regulation and in how such individuals modulate their emotional response to aversive events in their lives (e.g., emotional intelligence), now suggested by a recent study. As part of a new study, we examined the relationship between glycemic control (HbA1c) and Emotional Experience (ER-Exp) and Skill at Emotional Regulation (ER-Skill) in 100 adult patients with Type 2 Diabetes. We found significant relationships between ER-Exp and ER-Skill and HbA1c levels that accounted for nearly 24% of the variance in HbA1c levels. These relationships with HbA1c levels remained even after accounting for other relevant behavioral variables such as depression/anxiety scores and diabetes self-care/literacy scores. Accordingly, the tendency of an individual to have intense emotional responses (higher scores on ER-Exp), and/or to have a reduced ability to understand/modulate one's emotions in order to cope with daily stresses/threats (lower scores on ER-Skill), may well be linked with poor glycemic control (HbA1c) in adult patients with Type 2 Diabetes. If so, it will be important to develop psycho-social methods to improve ER-Exp and DR-Skill in Type 2 Diabetes patients to determine if one can improve aberrant Emotional Regulation (ER-Exp/ER-Skill), Diabetes Distress (DD), and HbA1c (A1c) levels as suggested by treatment studies showing that such treatment can improve ER-Skill with a sustained reduction in A1c levels in Type 2 Diabetes for up to nine months. Supporting these findings are data from a recent study showing that increasing positive emotion reduces (and increasing negative emotion increases) blood glucose levels, especially in those with poor emotion regulation skills.

Specific Study Objectives:

• Develop an integrated Emotion - Focused Psycho-social EF-CBT) from three (3) existing sources that contain elements to improve ER-Exp and ER-Skill.

• Conduct a pilot study in 10 patients with Type 2 Diabetes with aberrant ER-ER-Exp/ER-Skill and compare treatment outcomes in emotionality, diabetes distress, and in A1c levels with 10 patients with Type 2 Diabetes undergoing treatment as usual (TAU).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: October 19, 2018
• Est. primary completion date: October 19, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Receiving care for T2D at Kovler Diabetes Center, at UCM, or in the community.

2. Documented diagnosis of T2D for at least one year.

3. Age: 21-65 years of age.

4. HbA1c > 7.0 (with hemoglobin in the normal range).

5. ER-Exp Screen score of > 29 and/or ER-Skill Screen score < 44.

6. Stable medical co-morbid conditions.

7. Able to read English.

8. Able to give informed consent.

Exclusion Criteria:

1. Documented diagnosis of T2D less than one year.

2. Age: < 21 or > 65 years of age.

3. HbA1c < 7.0 .

4. ER-Exp screen score of < 29 and ER-Skill score =/> 44.

5. Unstable medical co-morbid conditions.

6. Active psychosis or suicidal/homicidal ideation.

7. Not able to read English.

8. Not able to give informed consent.

Related Conditions & MeSH terms

• Type2 Diabetes

Intervention

Behavioral:
• Emotion-Focused CBT
10 CBT Sessions to improve emotional regulation and emotional intelligence.

Locations

Country	Name	City	State
United States	University of Chicago	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in the ER-Exp Score	ER-Exp: Intensity and lability of negative emotion, higher scores indicate greater native emotionality	Baseline, mid-point, and end-point (about 10-12 weeks).
Primary	Change Score in ER-Skill Score	Skill at emotional regulation (Clarity and Repair). Lower scores indicate reduced skill at modulating negative emotions	Baseline, ,mid-point and end-point (about 10-12 weeks)
Primary	Change in HbA1c level	HbA1c levels	Baseline, mid-point, and end-point (about 10-12 weeks)
Primary	Change in Diabetes Distress	Distress at living with and coping with diabetes	Baseline, mid-point, and end-point (about 10-12 weeks)
Secondary	Change in Diabetes Self-Care	Self-Care Inventory-Revised: higher scores mean great efforts at self-care.	Baseline, mid-point, and end-point (about 10-12 weeks)